Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : RNA-based Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Discovery Platform
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Eclipsebio Launches eMERGE™ Platform for RNA Therapeutic Product Development
Details : eMERGE is an end-to-end solution for the characterization and optimization of RNA-based therapeutic products, including vaccines, protein and gene therapies, and monoclonal antibodies.
Brand Name : Undisclosed
Molecule Type : Vaccine
Upfront Cash : Not Applicable
July 24, 2024
Lead Product(s) : RNA-based Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Discovery Platform
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?